Carlyn Tan - Concepedia

Author

Carlyn Tan

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

C Tan, C. Tan, CHENG YIN TAN, Carlyn R Tan, Carlyn R. Tan, Carlyn Rose C. Tan, Carlyn Rose Co Tan, Carlyn Rose Tan, Carlyn Tan, Choonkeong Tan

252

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University Sylvester Comprehensive Cancer Center University of Miami Fox Chase Cancer Center

About

Carlyn Tan is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	1.2K
2	Health Sciences	7	7	583
3	Public Health	1	1	17
4	Cell Biology	1	1	68
5	Cellular Therapies	1	1	24

Carlyn Tan

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
GPRC5D-Targeted CAR T Cells for Myeloma Sham Mailankody, Sean M. Devlin, Jonathan Landa, New England Journal of Medicine	2022	367
Disease-free survival in children with Ewing's sarcoma treated with radiation therapy and adjuvant four-drug sequential chemotherapy Gerald Rosen, Norma Wollner, Carlyn Tan, Cancer Surgical OncologyAdjuvant ChemotherapyDisease-free SurvivalPharmacotherapyMetronomic Chemotherapy	1974	231
Carboplatin and recurrent childhood brain tumors. Jeffrey C. Allen, Russell Walker, Enrique Luks, Journal of Clinical Oncology Neuro-oncologyCisplatin AnalogueTumoral PathologyPediatric Brain TumorsMalignant Disease	1987	179
High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma Gerald Rosen, Songkiet Suwansirikul, Chae Hwa Kwon, Cancer PathologyPharmacotherapyMetronomic ChemotherapyRadiation MedicineAdriamycin Cyclic Chemotherapy	1974	175
NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020 Shaji Kumar, Natalie S. Callander, Jens Hillengaß, Journal of the National Comprehensive Cancer Network Hematological MalignancyUrologyMedicineMalignant Blood DisorderHematology	2019	169
Multidisciplinary treatment of embryonal rhabdomyosarcoma in children Fereshteh Ghavimi, Philip R. Exelby, Giulio J. D’Angio, Cancer	1975	168
Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma Stefan K. Barta, Jasmine Zain, Alexander W. Macfarlane, Clinical Lymphoma Myeloma & Leukemia Lymphoid NeoplasiaMedicineImmunologyPhase Ii StudyImmune Checkpoint Inhibitor	2019	117
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma Ola Landgren, Malin Hultcrantz, Benjamin Diamond, JAMA Oncology	2021	114
Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial Benjamin Diamond, Neha Korde, Alexander M. Lesokhin, The Lancet Haematology Hematological MalignancyOncologyContinuous Lenalidomide MaintenanceHematologyMyeloid Neoplasia	2021	87
Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphocytic leukemia Tanya Trippett, Stephan Śchlemmer, Y Elisseyeff, Blood	1992	69

Page 1